Natiya Dzhakhaya

Natiya Dzhakhaya

Auto-generated profile, based on publicly available information

Natiya Dzhakhaya

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RMRoman Maslennikov
Roman Maslennikov
EPElena Poluektova
Elena Poluektova
OZOksana Zolnikova
Oksana Zolnikova
ASAlla Sedova
Alla Sedova
AKAnastasia Kurbatova
Anastasia Kurbatova
VIVladimir Ivashkin
Vladimir Ivashkin
Cirrhosis is the end result of liver fibrosis in chronic liver diseases. Studying the mechanisms of its development and developing measures to slow down and regress it based on this knowledge seem to be important tasks for medicine. Currently, disorders of the gut–liver axis have great importance in the pathogenesis of cirrhosis. However, gut dysbiosis, which manifests as increased proportions in the gut microbiota of Bacilli and Proteobacteria that are capable of bacterial translocation and a decreased proportion of Clostridia that strengthen the intestinal barrier, occurs even at the pre-cirrhotic stage of chronic liver disease. This leads to the development of bacterial translocation, a process by which those microbes enter the blood of the portal vein and then the liver tissue, where they activate Kupffer cells through Toll-like receptor 4. In response, the Kupffer cells produce profibrogenic cytokines, which activate hepatic stellate cells, stimulating their transformation into myofibroblasts that produce collagen and other elements of the extracellular matrix. Blocking bacterial translocation with antibiotics, probiotics, synbiotics, and other methods could slow down the progression of liver fibrosis. This was shown in a number of animal models but requires further verification in long-term randomized controlled trials with humans.

19 September 2022 in Pulmonary Medicine
Verified
Journal Article
Open access
MOMariusz Ozimek
Mariusz Ozimek
VIVladimir Ivashkin
Vladimir Ivashkin
OZOksana Zolnikova
Oksana Zolnikova
NPNino Potskherashvili
Nino Potskherashvili
KIKonstantin Ivashkin
Konstantin Ivashkin
VZVictoria Zaborova
Victoria Zaborova
A Metabolic Activity Recovery of the Intestinal Microbiota in the Patients with Bronchial Asthma: Goals. We assessed the possibilities of correcting the short-chain fatty acids (SCFA) content and profiles in feces of patients with bronchial asthma. Background. It was established that the high biological diversity of intestinal microorganisms promotes the needed SCFAs production, which induces immune regulatory pathways and contributes to the anti-inflammatory response. Study. A group of 30 patients with allergic bronchial asthma (BA) were investigated in our study. All of the patients were tested for the presence of SIBO by the SCFA spectrum determination. For the SIBO treatment, 10 patients from the studied group were prescribed Rifaximinum with the 200 mg dose at 3 times a day for a week; the other 10 patients were prescribed Rifaximinum at the same dose, followed by the administration of the Lactobalance probiotic in capsules at 3 times a day for a month. A month probiotic course was assigned to the remaining 10 patients without SIBO, as part of the BA complex therapy. The SCFA studies were immediately carried out for all of the patients after the 1 month probiotic therapy course. Results. A normalization of the SCFA spectrum and anaerobic index for all of the studied patients were noted. Upon taking the probiotics, it was revealed in the patients without SIBO that the total content of fatty acids ( ), acetic and butyric acid ( ) had increased. The Rifaximinum course, followed by administration of the probiotics led to a decrease of the relative amount of isoacids and ratio of isoacids/acids in the studied patients as compared to the patients who had received Rifaximinum for the SIBO treatment only ( ). Conclusion. The obtained results demonstrate a potential opportunity of the drug influence on the active bacterial metabolites composition and amount in the intestinal biotope; as it was confirmed by the restoration of the intestinal microbiocenosis and microorganism habitat.

6 December 2020 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
VIV. T. Ivaschkin
V. T. Ivaschkin
OZOksana Zolnikova
Oksana Zolnikova
ASA. A. Svistunov
A. A. Svistunov
NDN. L. Dzhakhaya
N. L. Dzhakhaya
NPN. D. Potskhverashvili
N. D. Potskhverashvili
МНМ. Ю. Надинская
М. Ю. Надинская
Aim. To explore the effectiveness of corticosteroids in patients with lung damage caused by SARS-CoV-2.Materials and methods. The retrospective study included patients with confirmed SARS-CoV-2 infection and lung damage diagnosed by computed tomography (CT), who was receiving low molecular weight heparin (LMWH). 56 patients included in Group 1 received dexamethasone 4–12 mg/day for 8–10 days after admission to the hospital. 30 patients included in Group 2 (control group) had no dexamethasone treatment. The laboratory and instrumental data obtained from the patients under admission and for the 8–10th day of the treatment were analyzed. Hospital mortality was evaluated by Kaplan — Meier method. To predict a lethal outcome, we have used the logistic regression method. Results. By the 8–10th day of hospitalization, only in the Group 1, there was a statistically significant decrease in the volume of lung tissue lesions by CT (p = 0.027), fibrinogen concentration (p = 0.001). A statistically significant decrease of the C-reactive protein concentration was noted for the both groups. Oxygen therapy was more often needed in Group 2 (26 patients — 87%) in opposite to Group 1 (36 patients — 64%) (p = 0.028). Hospital mortality was 3.6% in Group 1 and 13.3% in Group 2 (p = 0.177). There was a trend towards an increase in patient survival in Group 1 between 18 and 28 days of hospitalization (Mantel — Cox test, p = 0.095). Age (p = 0.012), percentage of CT lesions at the time of admission (p = 0.020) and assignment to the dexamethasone group (p = 0.080) were included in the logistic regression equation.Conclusion. For the patients with SARS-CoV-2 lung damage, treatment with dexamethasone 4–12 mg, started from the first day of hospitalization additionally to LMWH, contributes to positive CT dynamics on the 8–10th day and decreases hospital mortality.

31 December 2020 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
OZOksana Zolnikova
Oksana Zolnikova
NDN. L. Dzhakhaya
N. L. Dzhakhaya
NPN. D. Potskherashvili
N. D. Potskherashvili
KPK. B. Puzakov
K. B. Puzakov
OКO. Yu. Кiseleva
O. Yu. Кiseleva
IКI. I. Коmkova
I. I. Коmkova
Aim. Analysis of clinical manifestations, laboratory and instrumental examination data in SARS-CoV-2 patients with taking into account the disease severity and outcome.Materials and methods. The study included 92 patients with confirmed coronavirus infection, including 15 lethal cases, hospitalised at the Vasilenko Clinic of Internal Disease Propaedeutics, Gastroenterology and Hepatology of the Sechenov University in April 2020. The analysis included demographic data, the presence of concomitant diseases, chest computed tomography (CT) results, laboratory tests (including SARS-CoV-2-diagnostic PCR, general and metabolic blood panels, coagulogram) and the duration of disease.Results. Patients infected with SARS-CoV-2 usually exhibit lymphopenia (p ≤ 0.001), leucocytosis, the elevated neutrophils (p ≤ 0.05), neutrophil-lymphocyte ratio (p ≤0,05), C-reactive protein (p ≤ 0.05), ferritin (p ≤ 0.05), D-dimer (p ≤ 0.05) and fibrinogen (p ≤ 0.05), altered prothrombin time (p ≤ 0.05) and INR (p ≤ 0.05). In a critical coronavirus infection, the pulmonary lesion exceeds 50% (corresponds to CT3 — CT4). The risk of critical SARS-CoV-2 infection increases with elder age (p ≤ 0.001), associates with the male gender and presence of concomitant diseases, such as obesity (p < 0.01), diabetes mellitus (p < 0.001), hypertension (p ≤ 0.001), CHD (p ≤ 0.001) and atrial fibrillation (p <0.05).Conclusion. The risk of severe and adverse coronavirus infection is significantly higher in elder comorbid patients.

12 July 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MOMariusz Ozimek
Mariusz Ozimek
VZVictoria Zaborova
Victoria Zaborova
OZOksana Zolnikova
Oksana Zolnikova
NDNatiya Dzhakhaya
Natiya Dzhakhaya
EBElena Bueverova
Elena Bueverova
Tadeusz AmbrożyTadeusz Ambroży
Tadeusz Ambroży
Background: To study the possibilities of using phytopreparations to increase the adaptive capabilities of the animals on which the experiments were conducted in swimming. Methods: 100 mongrel male rats were divided into 5 groups of 20 animals in each one. For 30 days running, the animals were immersed for 10 min in a bath with water at a temperature of +4 °C. In addition to cold exposure, the animals of the first three groups were injected per os with stress protectors 30 min before the immersion in water. The rats of the first group received an inhibitor of the enzyme gamma-butyrobetaine hydroxylase, the second group was given an extract of Eleutherococcus, and the third group took an extract of Ligusticum wallichii. As a placebo, to control the effect of the stress protectors, the rats of the fourth group were injected per os with 0.9% NaCl solution, and the animals in the fifth group were not given any drugs. On days 1, 4 and 30 of the experiment, five randomly selected animals from each group were decapitated, the heart and liver were removed, and the activity of tissue enzymes—superoxide dismutase (SOD), glutathione peroxidase (GPO), alanine aminotransferase (ALT), and aspartate aminotransferase (AST)—was analyzed. Results: The animals in the control group displayed a decrease in the activity of most of the studied enzymes, increasing from the 1st to the 30th day of the experiment. The NaCl solution had practically no effect on the analyzed parameters. Against the use of the enzyme gamma-butyrobetaine hydroxylase inhibitor, the activity of the enzymes did not change as compared with the pre-intervention level. On the first day of ingestion, the effects of the Ligusticum wallichii extract were similar to those of the enzyme gamma-butyrobetaine hydroxylase inhibitor. On the 30th day of ingestion, the effects of the Eleutherococcus extract were practically indistinguishable from those of the enzyme gamma-butyrobetaine hydroxylase inhibitor. Conclusions: The data obtained suggest the presence of cytoprotective effects in the two phytopreparations that are similar to the enzyme gamma-butyrobetaine hydroxylase inhibitor. In this case, the effect of the extract of Ligusticum wallichii is more pronounced under the acute stress conditions, and the extract of Eleutherococcus, under the chronic stress conditions.

30 December 2022 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
VIVladimir Ivashkin
Vladimir Ivashkin
EBE. K. Baranskaya
E. K. Baranskaya
YSYu. O. Shulpekova
Yu. O. Shulpekova
SKS. S. Kardasheva
S. S. Kardasheva
NDN. L. Dzhakhaya
N. L. Dzhakhaya
On October 21, 22, 23, 2022, within the framework of the 122nd International Session of the National School of Gastroenterology, Hepatology (NSGH) of the Russian Gastroenterological Association (RGA), the First Russian Gastroenterology Olympiad was held.